ArticleJournal of the American Society of Nephrology : JASN2025
Characterization of the Cystic Phenotype Associated with Monoallelic ALG8 and ALG9 Pathogenic Variants.
Abstract read
In one paragraph
Article in Journal of the American Society of Nephrology : JASN, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- Monogenic Etiologies of Kidney Cysts in the Pediatric Population: An Observational Cohort Study.Clinical journal of the American Society of Nephrology : CJASN · 2026Observational
- Genetic Testing in the Management of Adult CKD.Journal of the American Society of Nephrology : JASN · 2026Article
- Commemorating the National Institute of Diabetes and Digestive and Kidney Diseases' Advances in Kidney Health: 75 Years of Discovery and Impact.Journal of the American Society of Nephrology : JASN · 2026Article
- The Hidden Iceberg of ADPKD: Early Organomegaly-Driven Malnutrition and Sarcopenia Beyond Preserved eGFR.International journal of molecular sciences · 2026Review
- Characterization of Kidney and Liver Cystic Phenotype Associated with GANAB Using Advanced Imaging Biomarkers.Nephron · 2026Article
- Atypical presentations of fetal polycystic kidney disease demonstrates the utility of a genomic autopsy for accurate post-mortem diagnoses.Human genomics · 2025Article
- Commemorating the National Institute of Diabetes and Digestive and Kidney Diseases' Advances in Kidney Health: 75 Years of Discovery and Impact.Clinical journal of the American Society of Nephrology : CJASN · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
42 authors.
Tabinda JawaidDivision of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota.ORCID 0009-0000-6742-1422
Doaa E ElbarougyDivision of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota.ORCID 0009-0000-6487-8312
Sravanthi LavuDivision of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota.ORCID 0000-0001-7840-3852
Guillaume BuiaInserm, UMR 1078, GGB, CHU Brest, University of Brest, Brest, France.
Sarah R SenumDivision of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota.ORCID 0000-0002-5489-9117
Eric OlingerFaculty of Medical Sciences, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom.ORCID 0000-0003-1178-7980
Hana YangDivision of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota.
Shannon K McDonnellDepartment of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota.ORCID 0000-0001-6201-369
Joshua T BublitzDepartment of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota.
Jun MaDivision of Computational Biology, Mayo Clinic, Rochester, Minnesota.ORCID 0000-0003-4354-2523
Marie-Pierre AudrézetInserm, UMR 1078, GGB, CHU Brest, University of Brest, Brest, France.ORCID 0000-0003-0161-9473
Charles D MadsenDivision of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota.ORCID 0000-0002-7239-4593
Rachel S SchauerDivision of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota.ORCID 0009-0008-0224-6174
Tracy A BakerDivision of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota.ORCID 0009-0003-0620-3968
Adriana V GregoryDivision of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota.ORCID 0000-0001-9760-5302
Sarah E OrrFaculty of Medical Sciences, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom.ORCID 0009-0004-2373-8355
Miguel Barroso-GilFaculty of Medical Sciences, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom.ORCID 0000-0001-8245-1929
Ruxandra NeatuFaculty of Medical Sciences, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom.ORCID 0000-0003-0639-2175
Giancarlo JoliDivision of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota.
Neera K DahlDivision of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota.ORCID 0000-0001-5809-9961
Timothy L KlineDepartment of Radiology, Mayo Clinic, Rochester, Minnesota.ORCID 0000-0002-7917-9853
Valentine GillionDivision of Nephrology, Cliniques Universitaires Saint-Luc, UCLouvain, Brussels, Belgium.ORCID 0000-0002-3319-5233
Karin DahanEuropean Reference Network for Rare Kidney Diseases (ERKNet), Center of Human Genetics, Charleroi, Belgium.
Francois JouretDivision of Nephrology, University of Liège, Liège, Belgium.ORCID 0000-0003-2547-6593
Ronald D PerroneDivision of Nephrology, Tufts Medical Center and Tufts University School of Medicine, Boston, Massachusetts.ORCID 0000-0002-4963-1132
Theodore I SteinmanRenal Division, Beth Israel Deaconess Medical Center, Boston, Massachusetts.
Dorien J M PetersDepartment of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands.ORCID 0000-0001-6974-7143
Berenice Y GitomerDivision of Renal Diseases and Hypertension, University of Colorado School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado.ORCID 0000-0002-7457-6497
Terry J WatnickDivision of Nephrology, University of Maryland School of Medicine, Baltimore, Maryland.ORCID 0000-0003-0812-7279
Eliecer CotoDepartment of Medicine and RICORS-2040 (Kidney Disease), University of Oviedo, Oviedo, Spain.
Fouad T ChebibDivision of Nephrology and Hypertension, Mayo Clinic, Jacksonville, Florida.ORCID 0000-0002-3949-5720
Marie C HoganDivision of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota.ORCID 0000-0003-3031-8522
Janet E OlsonDivision of Epidemiology, Mayo Clinic, Rochester, Minnesota.ORCID 0000-0003-4944-7789
Nicholas B LarsonDepartment of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota.ORCID 0000-0002-3468-4215
Elisabet ArsMolecular Biology Laboratory, Fundació Puigvert, Instituto de Investigaciones Biomédicas Sant Pau (IIB-Sant Pau), RICORS2040 (Kidney Disease), Universitat Autònoma de Barcelona, Barcelona, Spain.ORCID 0000-0002-4118-4358
Jan HalbritterDepartment of Nephrology, Charité - Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.ORCID 0000-0002-1377-9880
Nathalie DemoulinDivision of Nephrology, Cliniques Universitaires Saint-Luc, UCLouvain, Brussels, Belgium.ORCID 0000-0002-3566-3950
Vicente E TorresDivision of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota.ORCID 0000-0003-2008-1576
John A SayerFaculty of Medical Sciences, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom.ORCID 0000-0003-1881-3782
Emilie Cornec-Le GallInserm, UMR 1078, GGB, CHU Brest, University of Brest, Brest, France.ORCID 0000-0003-1958-4459
Peter C HarrisDivision of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota.ORCID 0000-0002-5304-6593
Genomics England Research Consortium, UK Biobank, HALT PKD, DIPAK, TAME PKD, Genkyst studies, Mayo Clinic Biobank, and Regeneron Genetics Center
Funding
Pilot and FeasibilityP30DK090728 · NIDDK · MAYO CLINIC ROCHESTER · PI TORRES, VICENTE E · 2010 to 2019
$11.8MADPKD:Disease Spectrum &Genotype-Phenotype CorrelationsR01DK058816 · NIDDK · MAYO CLINIC ROCHESTER · PI Peter C. Harris · 2001 to 2026
$11.3MPKD Innovation and Resource Development CoreU54DK126114 · NIDDK · UNIVERSITY OF MARYLAND BALTIMORE · PI Stephen L. Seliger · 2020 to 2026
$7.3MAgence Nationale de la Recherche ANR JCJC 2019 GENOVAS-PKDEuropean Rare Kidney Disease Reference Network 739532Kidney Research UK ST_001_20171120Kidney Research UK Grant Paed_RP_001_20180925MRC MR/Y007808/1National Plan for Clinical Research (PHRC inter-regional GeneQuest NCT02112136NIDDK NIH HHS DK058816NIDDK NIH HHS DK090728NIDDK NIH HHS P30 DK090728NIDDK NIH HHS R01 DK058816NIDDK NIH HHS U54 DK126114Northern Counties Kidney Research Fund 20/01Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung P2ZHP3_195181Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung P500PB_206851
Abstract
PubMed holds no abstract for this paper.
Indexed as
ADPKDgenetic diseases and developmentnephropathypolycystic kidney disease
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.